Impact of tranexamic acid on bleeding during coronary artery bypass for patients under treatment of low molecular weight heparin

Impact of tranexamic acid on bleeding during coronary artery bypass for patients under treatment of low molecular weight heparin

Aim: Tranexamic acid (TA) is an antifibrinolytic agent that prevents the dissolution of fibrin clot. We investigated the impact of the use of tranexamic acid (TA) on bleeding for patients under treatment of low molecular weight heparin during coronary artery bypass graft (CABG) operations. Methods:...

Full description

Bibliographic Details
Main Authors: Ayşe Baysal, Öznur Uludag, Cengiz Güven, Fahriye Güler, Mevlüt Doğukan
Format: Article
Language:English
Published: Journal of Surgery and Medicine 2020-04-01
Series:Journal of Surgery and Medicine
Subjects:
coronary bypass surgery
low molecular weight heparin
tranexamic acid
bleeding
blood products
koroner bypass cerrahisi
düşük molekül ağırlıklı heparin
traneksamik asit
kanama
kan ürünleri
Online Access:https://dergipark.org.tr/en/pub/josam/issue/53710/713471

Internet

https://dergipark.org.tr/en/pub/josam/issue/53710/713471

Similar Items